COFCO Biotechnology has issued its half-year performance forecast for 2026, projecting a net loss attributable to shareholders of the listed company of 150 million to 190 million yuan for the first half, compared with a profit of 107 million yuan in the same period last year, a year-on-year decline of 240% to 277%. Net profit after deducting non-recurring items is expected to be a loss of 131 million to 171 million yuan, down 511% to 636% year-on-year. The company said that rising prices of raw materials such as corn and cassava have led to higher procurement costs, while the price increases for major products like fuel ethanol, starch, starch sugar, and citric acid have lagged far behind the rise in raw material costs, causing the raw-to-product price spread to narrow continuously and significantly squeezing profitability. This performance forecast is a preliminary estimate and has not been audited.
Cofco Biochemical Anhui Co LtdRising raw material costs (corn, cassava) squeeze margins, causing projected loss.